Carbamic acid, N-[2-(1H-indol-3-yl)ethyl]-N-methyl-, 1,1-dimethylethyl ester

N10-Methyl-N10-Boc-tryptamine is an intermediate used in the synthesis of Indralin (I521120), which acts as a radiation protective agent as well as acting as a vasoconstrictor, however not as effective as adrenaline. Indralin is also an α1-Adrenergic agonist. It was designed to prevent the acute radiation damage at exposures to a high dose of ionizing radiation.